Femoral head perfusion and composition: MR imaging and spectroscopic evaluation of patients with systemic lupus erythematosus and at risk for avascular necrosis

Radiology. 1995 Nov;197(2):433-8. doi: 10.1148/radiology.197.2.7480688.

Abstract

Purpose: To measure fat content and relative marrow perfusion of the femoral head in patients at risk for avascular necrosis.

Materials and methods: Thirteen patients with systemic lupus erythematosus (SLE) without avascular necrosis and with long-term corticosteroid treatment and 12 healthy subjects were evaluated. Hip perfusion was assessed with gadolinium-enhanced T1-weighted magnetic resonance (MR) imaging. Marrow composition in the femoral head and neck was measured with hydrogen-1 MR spectroscopy.

Results: Percentage fat content in the femoral head was similar between the two groups (SLE patients, 77% +/- 5 [standard deviation]; healthy subjects, 78% +/- 6; P = .74). Rate of enhancement of the femoral head was significantly higher in the SLE than the healthy group (11%/min +/- 6 vs 6.9%/min +/- 3, respectively; P = .05), was inversely related to fat content in healthy subjects (r = -.74, P = .02), and was more variable in the SLE group (r = -.53, P = .11).

Conclusion: Perfusion of the femoral head is inversely related to marrow fat content in healthy and is higher in SLE patients without hip avascular necrosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adipose Tissue / pathology
  • Adolescent
  • Adult
  • Bone Marrow / blood supply
  • Bone Marrow / pathology
  • Case-Control Studies
  • Contrast Media
  • Drug Combinations
  • Female
  • Femur Head / blood supply*
  • Femur Head / pathology*
  • Femur Neck / blood supply
  • Femur Neck / pathology
  • Gadolinium
  • Gadolinium DTPA
  • Hip Joint / blood supply
  • Hip Joint / pathology
  • Humans
  • Image Enhancement
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / pathology*
  • Magnetic Resonance Imaging* / methods
  • Magnetic Resonance Spectroscopy* / methods
  • Male
  • Meglumine
  • Middle Aged
  • Organometallic Compounds
  • Osteonecrosis / pathology*
  • Pentetic Acid / analogs & derivatives
  • Prednisone / administration & dosage
  • Prednisone / therapeutic use
  • Regional Blood Flow
  • Risk Factors

Substances

  • Contrast Media
  • Drug Combinations
  • Organometallic Compounds
  • Meglumine
  • Pentetic Acid
  • Gadolinium
  • Gadolinium DTPA
  • Prednisone